Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Poster presentation – Abstract #41 A New Microfluidic Platform Capturing Circulating Tumor Cells from Metastatic Breast Cancer Patients by Both Affinity and Size Peter J Maimonis1, Kurt...
-
WALTHAM, Mass., Aug. 6, 2010 (GLOBE NEWSWIRE) -- On-Q-ity, a next-generation oncology diagnostics company developing products to improve cancer therapy effectiveness, today announced that the...
-
On-Q-ity to Present Three Abstracts at ASCO Related to Biomarkers to Predict Cancer Therapy Response
WALTHAM, Mass., June 4, 2010 (GLOBE NEWSWIRE) -- On-Q-ity, a next-generation oncology diagnostics company developing personalized tests to improve cancer therapy effectiveness, today announced that it...
-
WALTHAM, Mass., Jan. 7, 2010 (GLOBE NEWSWIRE) -- On-Q-ity, a next-generation oncology diagnostics company developing products to improve cancer therapy efficacy, ended 2009 with a total of $26 million...
-
WALTHAM, Mass., Dec. 14, 2009 (GLOBE NEWSWIRE) -- On-Q-ity, a next-generation oncology diagnostics company developing products to improve cancer therapy effectiveness, today announced that it has...
-
WALTHAM, Mass., Dec. 8, 2009 (GLOBE NEWSWIRE) -- On-Q-ity, a next-generation oncology diagnostics company developing products to improve cancer therapy effectiveness, announced today the appointment...